US Equity · NASDAQ · Earnings Dossier

ILMN earnings intelligence

Illumina Inc

Healthcare · Diagnostics & Research · USD reporting basis

Current earnings profile Delivery strong, expectations demanding

Results have usually cleared estimates, but price has not consistently rewarded the delivery.

Evidence100/100 · Deep

Next scheduled catalyst

No forward date is currently stored

The historical dossier remains available while the next calendar date is unconfirmed.

0event risk

Inactive

Countdown-calendar proximity
EPS estimate-provider consensus
Estimate growth-versus comparable year-ago actual
Historical movement9.6%average absolute next weekly close

Three-year earnings transmission

Delivered earnings power versus market price

Earnings ahead

Earnings power is leading market price; the spread is stable and has persisted through 12 updates. Both series begin at 100, so the gap isolates the relative change in price and trailing earnings power.

Market move24.1%2023-08-25 to 2026-08-14
Earnings move485.2%trailing diluted EPS
Unresolved spread461.1 ptsStable
Current multiple37.1xprice divided by TTM EPS
Relationship pressure89/100Extreme
Model confidence67/100Moderate

Move decomposition

Earnings contribution and valuation offset

The market move is separated into the change in trailing earnings power and the offset from relative valuation.

Relationship controls

What qualifies the headline spread

Persistent earnings lead

Earnings power has led market price across several updates.

Business quality supportive

Cash generation and operating evidence are broadly supportive.

Price confirmation reversed

The latest earnings improvement initially received a positive price response, but price is now below its pre-update level.

Starting-base sensitivity

The three-year earnings move begins from an unusually depressed level; compare the shorter horizons before relying on its scale.

Model qualification

The three-year starting earnings level was unusually depressed.

Model qualification

The earnings move is exceptionally large and should be read with its quality confirmation.

Model qualification

The direction is sensitive to the comparison horizon.

Beat rate75.0%9 beats in 12 measured quarters
Average surprise+13.1%median 9.1%
Delivery streak66 consecutive beats
Average response-2.7%12 measured reactions
Result-price confirmation46%same directional sign
Surprise variability43.0 ptspopulation dispersion

Estimate delivery

Actual EPS versus consensus

Actual and estimated EPS are displayed in reported currency on the same quarterly basis.

Price acceptance

Surprise and next weekly close

The response uses the first completed weekly close after the public report against the prior completed weekly close.

Fundamental delivery

Quarterly revenue and net income

Reported financial statements provide scale and earnings quality context around the headline EPS result.

Transmission matrix

Does price confirm delivery?

Upper right and lower left observations confirm the sign of delivery. The other quadrants expose expectation or resilience effects.

Current business context

Growth, quality and valuation

As of 9 Aug 2026
EPS growth-34.4%year on year
Revenue growth4.9%year on year
Average surprise9.8%latest four quarters
SUE0.98standardised surprise
Net margin18.4%trailing basis
Cash conversion1.52xcash flow / net income
P/E34.4xcurrent snapshot
Data completeness100%alphavantage

Market context

Positioning into the event

Week ending 14 Aug 2026
Weekly close190.89 USDcompleted week
13-week return33.9%price momentum
Fair-value gap54.8%price versus current fair value
Relative strength23.5exchange benchmark
Trend signalActiveweekly architecture
Next-week stateUndecided52.8%

Market context describes the setup surrounding the report. It does not convert the earnings event into a directional forecast.

Reported evidence ledger

Quarter-by-quarter delivery and acceptance

Each row preserves the reported estimate, public date, statement context and conservative weekly reaction measurement.

12 quarters
Reported / periodEPS actual / estimateSurpriseEPS growthRevenue / growthNext close / four weeksRead
Reported / period30 Jul 202630 Jun 2026 · exact
EPS actual / estimate1.31 / 1.23USD
Surprise+6.5%Beat
EPS growth+10.1%year on year
Revenue / growth1159000000+9.6% · USD
Next close / four weeks+5.7% / -completed weekly closes
ReadConfirmedresult versus price sign
Reported / period30 Apr 202631 Mar 2026 · exact
EPS actual / estimate1.15 / 1.06USD
Surprise+8.5%Beat
EPS growth+18.6%year on year
Revenue / growth1091000000+4.8% · USD
Next close / four weeks+6.2% / +12.9%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period5 Feb 202631 Dec 2025 · exact
EPS actual / estimate1.35 / 1.23USD
Surprise+9.8%Beat
EPS growth+57.0%year on year
Revenue / growth1160000000+5.1% · USD
Next close / four weeks-17.3% / -7.1%completed weekly closes
ReadDivergedresult versus price sign
Reported / period30 Oct 202530 Sep 2025 · exact
EPS actual / estimate1.34 / 1.17USD
Surprise+14.5%Beat
EPS growth+17.5%year on year
Revenue / growth1083000000+0.3% · USD
Next close / four weeks+23.4% / +23.7%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period31 Jul 202530 Jun 2025 · exact
EPS actual / estimate1.19 / 1.01USD
Surprise+17.8%Beat
EPS growth+230.6%year on year
Revenue / growth1057000000-4.9% · USD
Next close / four weeks-13.4% / -6.9%completed weekly closes
ReadDivergedresult versus price sign
Reported / period8 May 202531 Mar 2025 · exact
EPS actual / estimate0.97 / 0.94USD
Surprise+3.2%Beat
EPS growth+977.8%year on year
Revenue / growth1041000000-3.3% · USD
Next close / four weeks-2.7% / +5.6%completed weekly closes
ReadDivergedresult versus price sign
Reported / period6 Feb 202531 Dec 2024 · exact
EPS actual / estimate0.86 / 0.92USD
Surprise-6.5%Miss
EPS growth+514.3%year on year
Revenue / growth1104000000-1.6% · USD
Next close / four weeks-16.3% / -33.1%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period4 Nov 202430 Sep 2024 · exact
EPS actual / estimate1.14 / 0.88USD
Surprise+29.5%Beat
EPS growth+245.5%year on year
Revenue / growth1080000000-3.5% · USD
Next close / four weeks+0.9% / -3.7%completed weekly closes
ReadContainedresult versus price sign
Reported / period6 Aug 202430 Jun 2024 · exact
EPS actual / estimate0.36 / 0.90USD
Surprise-60.0%Miss
EPS growth-year on year
Revenue / growth1112000000- · USD
Next close / four weeks+5.0% / +11.6%completed weekly closes
ReadDivergedresult versus price sign
Reported / period2 May 202431 Mar 2024 · exact
EPS actual / estimate0.09 / 0.11USD
Surprise-18.2%Miss
EPS growth-year on year
Revenue / growth1076000000- · USD
Next close / four weeks-3.6% / -12.9%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period8 Feb 202431 Dec 2023 · exact
EPS actual / estimate0.14 / 0.12USD
Surprise+16.7%Beat
EPS growth-year on year
Revenue / growth1122000000- · USD
Next close / four weeks-4.4% / -2.6%completed weekly closes
ReadDivergedresult versus price sign
Reported / period9 Nov 202330 Sep 2023 · exact
EPS actual / estimate0.33 / 0.14USD
Surprise+135.7%Beat
EPS growth-year on year
Revenue / growth1119000000- · USD
Next close / four weeks-15.9% / -6.1%completed weekly closes
ReadDivergedresult versus price sign

Reproducible method

How the earnings dossier is measured

Descriptive, not predictive
Estimate delivery

Reported diluted EPS is compared with the stored estimate for the same fiscal period. Moves within ±0.5% are classified as in-line.

Price response

The first completed weekly close after the public date is compared with the prior completed weekly close. Four-week response uses the first close at least 21 days later.

Event risk

Risk combines proximity, average absolute price movement, surprise variability, estimate availability and timing certainty. It does not score direction.

Data discipline

Exact public dates are used when stored. Missing estimates, timing and statement fields remain missing. No result or reaction is filled from a future observation.

Independent market research for education. Not investment advice, a recommendation, forecast, target or execution instruction.

Evidence context